Karen Firestone

Insider Reports History

Entity
Individual
Location
C/O Amylyx Pharmaceuticals, Inc., 43 Thorndike St., Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Firestone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Director Common Stock 55K $117K $2.13 Sep 5, 2024 Direct
Amylyx Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 6, 2024 Direct

Insider Reports Filed by Karen Firestone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMLX Amylyx Pharmaceuticals, Inc. Sep 5, 2024 1 $107K 4 Sep 9, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Dec 15, 2023 1 $59.9K 4 Dec 19, 2023 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 2 $32K 4 Mar 20, 2023 Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 0 $0 3 Mar 20, 2023 Director